NM_031407.7:c.8161-30C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_031407.7(HUWE1):c.8161-30C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0441 in 1,149,755 control chromosomes in the GnomAD database, including 3,121 homozygotes. There are 15,489 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.046 ( 321 hom., 1625 hem., cov: 22)
Exomes 𝑓: 0.044 ( 2800 hom. 13864 hem. )
Consequence
HUWE1
NM_031407.7 intron
NM_031407.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.761
Publications
21 publications found
Genes affected
HUWE1 (HGNC:30892): (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]
MIRLET7F2 (HGNC:31484): (microRNA let-7f-2) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant X-53557457-G-A is Benign according to our data. Variant chrX-53557457-G-A is described in ClinVar as Benign. ClinVar VariationId is 1226397.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.279 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HUWE1 | NM_031407.7 | c.8161-30C>T | intron_variant | Intron 59 of 83 | ENST00000262854.11 | NP_113584.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0458 AC: 5122AN: 111891Hom.: 320 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
5122
AN:
111891
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0900 AC: 16329AN: 181518 AF XY: 0.0736 show subpopulations
GnomAD2 exomes
AF:
AC:
16329
AN:
181518
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0439 AC: 45588AN: 1037811Hom.: 2800 Cov.: 25 AF XY: 0.0446 AC XY: 13864AN XY: 310725 show subpopulations
GnomAD4 exome
AF:
AC:
45588
AN:
1037811
Hom.:
Cov.:
25
AF XY:
AC XY:
13864
AN XY:
310725
show subpopulations
African (AFR)
AF:
AC:
175
AN:
25326
American (AMR)
AF:
AC:
10426
AN:
35113
Ashkenazi Jewish (ASJ)
AF:
AC:
442
AN:
19038
East Asian (EAS)
AF:
AC:
10412
AN:
29970
South Asian (SAS)
AF:
AC:
1534
AN:
52827
European-Finnish (FIN)
AF:
AC:
1438
AN:
39557
Middle Eastern (MID)
AF:
AC:
38
AN:
3975
European-Non Finnish (NFE)
AF:
AC:
19103
AN:
787837
Other (OTH)
AF:
AC:
2020
AN:
44168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1237
2473
3710
4946
6183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
962
1924
2886
3848
4810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0458 AC: 5122AN: 111944Hom.: 321 Cov.: 22 AF XY: 0.0476 AC XY: 1625AN XY: 34144 show subpopulations
GnomAD4 genome
AF:
AC:
5122
AN:
111944
Hom.:
Cov.:
22
AF XY:
AC XY:
1625
AN XY:
34144
show subpopulations
African (AFR)
AF:
AC:
345
AN:
30882
American (AMR)
AF:
AC:
2070
AN:
10544
Ashkenazi Jewish (ASJ)
AF:
AC:
67
AN:
2646
East Asian (EAS)
AF:
AC:
1031
AN:
3503
South Asian (SAS)
AF:
AC:
70
AN:
2687
European-Finnish (FIN)
AF:
AC:
217
AN:
6096
Middle Eastern (MID)
AF:
AC:
3
AN:
216
European-Non Finnish (NFE)
AF:
AC:
1229
AN:
53157
Other (OTH)
AF:
AC:
89
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
152
304
457
609
761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.